BCTXP Prep Course (BCTXP): free quiz

1. Question 1 of 10

   A kidney transplant recipient is postoperative day 7, CMV D+/R−, receiving valganciclovir 900 mg PO once daily for prophylaxis, tacrolimus 3 mg PO every 12 hours, and mycophenolate mofetil 1 g PO every 12 hours. Current Cockcroft-Gault CrCl is 18 mL/min, and the patient is not on dialysis. As the transplant pharmacist reviewing discharge medications, which recommendation is best?

   Choose one answer

   A

   Reduce valganciclovir to 450 mg PO once daily because renal function is impaired but expected to improve after transplant.

   B

   Reduce valganciclovir to 450 mg PO twice weekly while CrCl remains 10–24 mL/min, with CBC and renal function monitoring.

   C

   Reduce valganciclovir to 450 mg PO every 48 hours and give doses after dialysis if dialysis is later initiated.

   D

   Continue valganciclovir 900 mg PO once daily and monitor CBC because mycophenolate-related myelosuppression can be followed clinically.

2. Question 2 of 10

   A liver transplant candidate has cirrhosis with portal hypertension. The care team asks the pharmacist to review the supportive medication regimen. Which issue from the source pack most directly justifies this focused review?

   Choose one answer

   APortal hypertension can shape supportive regimens in liver failure.BPortal hypertension eliminates the need to consider medication absorption.CPortal hypertension is unrelated to liver transplant pharmacotherapy.DPortal hypertension makes post-transplant graft function irrelevant to dosing.
3. Question 3 of 10

   A pharmacist is evaluating a patient with advanced lung disease for transplant-related medication planning. The patient has oxygen therapy needs and pulmonary hypertension. Which statement best reflects the selected node?

   Choose one answer

   ABoth oxygen therapy and pulmonary hypertension can be relevant to the medication plan.BOxygen therapy is relevant, but pulmonary hypertension is never a cardiopulmonary comorbidity.CPulmonary hypertension is relevant only after long-term graft failure.DNeither oxygen therapy nor pulmonary hypertension affects transplant pharmacotherapy context.
4. Question 4 of 10

   A pharmacist is selecting the best educational objective for a lesson on pancreas and multi-organ transplant context. Which objective is most aligned with the source pack?

   Choose one answer

   ADifferentiate pancreas transplant contexts and apply integrated medication monitoring for glycemic and multi-organ issues.BMemorize transplant surgical instruments used in pancreas procurement.CExplain why post-transplant glycemic targets are unrelated to immunosuppressive medications.DExclude type 1 diabetes complications from transplant candidacy assessment.
5. Question 5 of 10

   A transplant pharmacist is asked to classify a suspected rejection event. The biopsy discussion includes T-cell-mediated injury rather than a primarily antibody-driven process. Which rejection phenotype best aligns with this mechanism?

   Choose one answer

   AAcute cellular rejectionBAntibody-mediated rejectionCHyperacute rejectionDChronic rejection
6. Question 6 of 10

   A transplant team is deciding between a more intensive and less intensive immunosuppression strategy. The patient has multiple antibody-risk features. Which principle should guide the pharmacist's recommendation?

   Choose one answer

   AImmunologic risk level should be matched to induction choice and maintenance intensity.BAntibody-risk features should be disregarded once the patient is listed.CAll patients should receive identical monitoring regardless of immunologic risk.DRace-ethnicity context is the only factor needed to select a regimen.
7. Question 7 of 10

   A desensitization protocol uses several agents to reduce antibody burden. Which monitoring omission would most directly conflict with the source pack?

   Choose one answer

   AOmitting CBC monitoringBOmitting a cosmetic dermatology scoreCOmitting a daily room assignment auditDOmitting a parking access survey
8. Question 8 of 10

   In the context of candidate evaluation medication issues, which pharmacist recommendation would be most inappropriate?

   Choose one answer

   AIndependently decide the transplant surgical procedure because the medication history is complex.BIdentify adherence barriers from the medication history.CReview vaccine status as part of pre-transplant planning.DConsider access barriers that may affect readiness.
9. Question 9 of 10

   During a pre-transplant medication review, a pharmacist identifies that a candidate's allocation urgency has increased. Which next step best reflects the medication-relevant role described in the source pack?

   Choose one answer

   AReview whether disease severity changes the safety or appropriateness of current therapies.BUse the allocation score to decide which organ the candidate should receive.CAvoid discussing pharmacotherapy until after the transplant operation.DRestrict the review to insurance coverage and exclude clinical medication issues.
10. Question 10 of 10

    An early postoperative transplant recipient has orders for several tablets, but gastrointestinal function is impaired. Which concept from the source pack should the pharmacist apply?

    Choose one answer

    AMedication route conversion is common early after transplant.BMedication delivery route is irrelevant in early transplant care.COnly outpatient prescriptions require route assessment.DRoute conversion is a surgical procedure that pharmacists should perform independently.

Check my answers